http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 12 May 2026 16:32:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++Ispire+Technology+Inc.+++++++++++++++/26478604.html si-local-file:///var/storage/secattach/20260512/26478604.html http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++Ispire+Technology+Inc.+++++++++++++++/26478604.html Tue, 12 May 2026 16:32:00 -0400 ISPR O.57534732 http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++Ispire+Technology+Inc.+++++++++++++++/26478604.html si-local-file:///var/storage/secattach/20260512/26478604.html http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++Ispire+Technology+Inc.+++++++++++++++/26478604.html Tue, 12 May 2026 16:32:00 -0400 ISPR O.57534732 http://www.streetinsider.com/SEC+Filings/Form++DEF+14A++++Ispire+Technology+Inc.++++For%3A+Jun+23/26478569.html si-local-file:///var/storage/secattach/20260512/26478569.html http://www.streetinsider.com/SEC+Filings/Form++DEF+14A++++Ispire+Technology+Inc.++++For%3A+Jun+23/26478569.html Tue, 12 May 2026 16:31:00 -0400 ISPR O.57534732 http://www.streetinsider.com/SEC+Filings/Form++DEF+14A++++Ispire+Technology+Inc.++++For%3A+Jun+23/26478569.html si-local-file:///var/storage/secattach/20260512/26478569.html http://www.streetinsider.com/SEC+Filings/Form++DEF+14A++++Ispire+Technology+Inc.++++For%3A+Jun+23/26478569.html Tue, 12 May 2026 16:31:00 -0400 ISPR O.57534732 http://www.streetinsider.com/Corporate+News/Ispire+Technology+forms+joint+venture+with+Jincheng+Pharma+for+nicotine+pouches/26473706.html <p>Ispire Technology Inc. (NASDAQ: ISPR) announced it has entered into a joint venture with Shandong Jincheng Pharmaceutical Group Co., Ltd. (SZSE: 300233) to manufacture and commercialize nicotine pouch products.</p> <p>The partnership marks Ispire's entry into the oral nicotine category, expanding beyond its existing vaping hardware business. According to Grand View Research, the nicotine pouch market was approximately $7 billion in 2025 and is projected to grow at nearly 25% annually through 2033, potentially exceeding $40 billion.</p> <p>Under the agreement, Jincheng Pharma will contribute manufacturing equipment, technical expertise, and nicotine pouch materials. The joint venture will leverage Ispire's precision dosing capabilities, regulatory compliance http://www.streetinsider.com/Corporate+News/Ispire+Technology+forms+joint+venture+with+Jincheng+Pharma+for+nicotine+pouches/26473706.html Tue, 12 May 2026 08:30:23 -0400 300233 ISPR O.07642199 O.57534732 http://www.streetinsider.com/Corporate+News/Ispire+Technology+forms+joint+venture+with+Jincheng+Pharma+for+nicotine+pouches/26473706.html <p>Ispire Technology Inc. (NASDAQ: ISPR) announced it has entered into a joint venture with Shandong Jincheng Pharmaceutical Group Co., Ltd. (SZSE: 300233) to manufacture and commercialize nicotine pouch products.</p> <p>The partnership marks Ispire's entry into the oral nicotine category, expanding beyond its existing vaping hardware business. According to Grand View Research, the nicotine pouch market was approximately $7 billion in 2025 and is projected to grow at nearly 25% annually through 2033, potentially exceeding $40 billion.</p> <p>Under the agreement, Jincheng Pharma will contribute manufacturing equipment, technical expertise, and nicotine pouch materials. The joint venture will leverage Ispire's precision dosing capabilities, regulatory compliance http://www.streetinsider.com/Corporate+News/Ispire+Technology+forms+joint+venture+with+Jincheng+Pharma+for+nicotine+pouches/26473706.html Tue, 12 May 2026 08:30:23 -0400 300233 ISPR O.07642199 O.57534732 http://www.streetinsider.com/Corporate+News/Ispire+Technology+forms+joint+venture+with+Jincheng+Pharma+for+nicotine+pouches/26473706.html <p>Ispire Technology Inc. (NASDAQ: ISPR) announced it has entered into a joint venture with Shandong Jincheng Pharmaceutical Group Co., Ltd. (SZSE: 300233) to manufacture and commercialize nicotine pouch products.</p> <p>The partnership marks Ispire's entry into the oral nicotine category, expanding beyond its existing vaping hardware business. According to Grand View Research, the nicotine pouch market was approximately $7 billion in 2025 and is projected to grow at nearly 25% annually through 2033, potentially exceeding $40 billion.</p> <p>Under the agreement, Jincheng Pharma will contribute manufacturing equipment, technical expertise, and nicotine pouch materials. The joint venture will leverage Ispire's precision dosing capabilities, regulatory compliance http://www.streetinsider.com/Corporate+News/Ispire+Technology+forms+joint+venture+with+Jincheng+Pharma+for+nicotine+pouches/26473706.html Tue, 12 May 2026 08:30:23 -0400 300233 ISPR O.07642199 O.57534732 http://www.streetinsider.com/Corporate+News/Ispire+Technology+forms+joint+venture+with+Jincheng+Pharma+for+nicotine+pouches/26473706.html <p>Ispire Technology Inc. (NASDAQ: ISPR) announced it has entered into a joint venture with Shandong Jincheng Pharmaceutical Group Co., Ltd. (SZSE: 300233) to manufacture and commercialize nicotine pouch products.</p> <p>The partnership marks Ispire's entry into the oral nicotine category, expanding beyond its existing vaping hardware business. According to Grand View Research, the nicotine pouch market was approximately $7 billion in 2025 and is projected to grow at nearly 25% annually through 2033, potentially exceeding $40 billion.</p> <p>Under the agreement, Jincheng Pharma will contribute manufacturing equipment, technical expertise, and nicotine pouch materials. The joint venture will leverage Ispire's precision dosing capabilities, regulatory compliance http://www.streetinsider.com/Corporate+News/Ispire+Technology+forms+joint+venture+with+Jincheng+Pharma+for+nicotine+pouches/26473706.html Tue, 12 May 2026 08:30:23 -0400 300233 ISPR O.07642199 O.57534732 http://www.streetinsider.com/Press+Releases/Ispire+Technology+Expands+Into+High-Growth+Nicotine+Pouch+Market+Through+Strategic+Joint+Venture+with+Jincheng+Pharma/26473674.html <div class="xn-content"> <p class="prntac"><i>Partnership combines pharmaceutical-grade manufacturing with Ispire's global platform to accelerate entry into one of the fastest-growing nicotine segments </i></p><p><span class="legendSpanClass"><location value="LU/us.ca.losang" idsrc="xmltag.org" >LOS ANGELES</location></span>, <span class="legendSpanClass"><chron>May 12, 2026</chron></span> /PRNewswire/ <b>-- </b><a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4685825-1&amp;h=609010424&amp;u=https%3A%2F%2Fispiretechnology.com%2F&amp;a=Ispire+Technology+Inc." target="_blank" rel="nofollow"><b><span value="NASDAQ-NMS:ISPR" idsrc="xmltag.org" >Ispire Technology Inc.</span></b></a> ("Ispire" or the "Company") (<a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4685825-1&amp;h=3905662850&amp;u=https%3A%2F%2Fwww.nasdaq.com%2Fmarket-activity%2Fstocks%2Fispr&amp;a=NASDAQ%3A+ISPR" target="_blank" rel="nofollow">NASDAQ: ISPR</a>), a trailblazer in vaping technology and precision dosing, announced that it has entered into a joint venture with <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4685825-1&amp;h=3130007742&amp;u=http%3A%2F%2Fwww.jinchengpharm.com%2Fwap_index_en.html&amp;a=Shandong+Jincheng+Pharmaceutical+Group+Co.%2C+Ltd." target="_blank" rel="nofollow"><span value="Shenzhen:300233" idsrc="xmltag.org" >Shandong Jincheng Pharmaceutical Group Co., Ltd.</span></a> (SZSE: 300233) ("Jincheng Pharma"), a global pharmaceutical company, to manufacture and commercialize nicotine pouch products.</p><div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder5003"><p><a target="_blank" href="https://mma.prnewswire.com/media/2771569/Ispire_Technology_Logo.html" http://www.streetinsider.com/Press+Releases/Ispire+Technology+Expands+Into+High-Growth+Nicotine+Pouch+Market+Through+Strategic+Joint+Venture+with+Jincheng+Pharma/26473674.html Tue, 12 May 2026 08:30:00 -0400 300233 ISPR O.07642199 O.57534732 http://www.streetinsider.com/Press+Releases/Ispire+Technology+Expands+Into+High-Growth+Nicotine+Pouch+Market+Through+Strategic+Joint+Venture+with+Jincheng+Pharma/26473674.html <div class="xn-content"> <p class="prntac"><i>Partnership combines pharmaceutical-grade manufacturing with Ispire's global platform to accelerate entry into one of the fastest-growing nicotine segments </i></p><p><span class="legendSpanClass"><location value="LU/us.ca.losang" idsrc="xmltag.org" >LOS ANGELES</location></span>, <span class="legendSpanClass"><chron>May 12, 2026</chron></span> /PRNewswire/ <b>-- </b><a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4685825-1&amp;h=609010424&amp;u=https%3A%2F%2Fispiretechnology.com%2F&amp;a=Ispire+Technology+Inc." target="_blank" rel="nofollow"><b><span value="NASDAQ-NMS:ISPR" idsrc="xmltag.org" >Ispire Technology Inc.</span></b></a> ("Ispire" or the "Company") (<a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4685825-1&amp;h=3905662850&amp;u=https%3A%2F%2Fwww.nasdaq.com%2Fmarket-activity%2Fstocks%2Fispr&amp;a=NASDAQ%3A+ISPR" target="_blank" rel="nofollow">NASDAQ: ISPR</a>), a trailblazer in vaping technology and precision dosing, announced that it has entered into a joint venture with <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4685825-1&amp;h=3130007742&amp;u=http%3A%2F%2Fwww.jinchengpharm.com%2Fwap_index_en.html&amp;a=Shandong+Jincheng+Pharmaceutical+Group+Co.%2C+Ltd." target="_blank" rel="nofollow"><span value="Shenzhen:300233" idsrc="xmltag.org" >Shandong Jincheng Pharmaceutical Group Co., Ltd.</span></a> (SZSE: 300233) ("Jincheng Pharma"), a global pharmaceutical company, to manufacture and commercialize nicotine pouch products.</p><div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder5003"><p><a target="_blank" href="https://mma.prnewswire.com/media/2771569/Ispire_Technology_Logo.html" http://www.streetinsider.com/Press+Releases/Ispire+Technology+Expands+Into+High-Growth+Nicotine+Pouch+Market+Through+Strategic+Joint+Venture+with+Jincheng+Pharma/26473674.html Tue, 12 May 2026 08:30:00 -0400 300233 ISPR O.07642199 O.57534732 http://www.streetinsider.com/Press+Releases/Ispire+Technology+Expands+Into+High-Growth+Nicotine+Pouch+Market+Through+Strategic+Joint+Venture+with+Jincheng+Pharma/26473674.html <div class="xn-content"> <p class="prntac"><i>Partnership combines pharmaceutical-grade manufacturing with Ispire's global platform to accelerate entry into one of the fastest-growing nicotine segments </i></p><p><span class="legendSpanClass"><location value="LU/us.ca.losang" idsrc="xmltag.org" >LOS ANGELES</location></span>, <span class="legendSpanClass"><chron>May 12, 2026</chron></span> /PRNewswire/ <b>-- </b><a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4685825-1&amp;h=609010424&amp;u=https%3A%2F%2Fispiretechnology.com%2F&amp;a=Ispire+Technology+Inc." target="_blank" rel="nofollow"><b><span value="NASDAQ-NMS:ISPR" idsrc="xmltag.org" >Ispire Technology Inc.</span></b></a> ("Ispire" or the "Company") (<a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4685825-1&amp;h=3905662850&amp;u=https%3A%2F%2Fwww.nasdaq.com%2Fmarket-activity%2Fstocks%2Fispr&amp;a=NASDAQ%3A+ISPR" target="_blank" rel="nofollow">NASDAQ: ISPR</a>), a trailblazer in vaping technology and precision dosing, announced that it has entered into a joint venture with <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4685825-1&amp;h=3130007742&amp;u=http%3A%2F%2Fwww.jinchengpharm.com%2Fwap_index_en.html&amp;a=Shandong+Jincheng+Pharmaceutical+Group+Co.%2C+Ltd." target="_blank" rel="nofollow"><span value="Shenzhen:300233" idsrc="xmltag.org" >Shandong Jincheng Pharmaceutical Group Co., Ltd.</span></a> (SZSE: 300233) ("Jincheng Pharma"), a global pharmaceutical company, to manufacture and commercialize nicotine pouch products.</p><div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder5003"><p><a target="_blank" href="https://mma.prnewswire.com/media/2771569/Ispire_Technology_Logo.html" http://www.streetinsider.com/Press+Releases/Ispire+Technology+Expands+Into+High-Growth+Nicotine+Pouch+Market+Through+Strategic+Joint+Venture+with+Jincheng+Pharma/26473674.html Tue, 12 May 2026 08:30:00 -0400 300233 ISPR O.07642199 O.57534732 http://www.streetinsider.com/Press+Releases/Ispire+Technology+Expands+Into+High-Growth+Nicotine+Pouch+Market+Through+Strategic+Joint+Venture+with+Jincheng+Pharma/26473674.html <div class="xn-content"> <p class="prntac"><i>Partnership combines pharmaceutical-grade manufacturing with Ispire's global platform to accelerate entry into one of the fastest-growing nicotine segments </i></p><p><span class="legendSpanClass"><location value="LU/us.ca.losang" idsrc="xmltag.org" >LOS ANGELES</location></span>, <span class="legendSpanClass"><chron>May 12, 2026</chron></span> /PRNewswire/ <b>-- </b><a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4685825-1&amp;h=609010424&amp;u=https%3A%2F%2Fispiretechnology.com%2F&amp;a=Ispire+Technology+Inc." target="_blank" rel="nofollow"><b><span value="NASDAQ-NMS:ISPR" idsrc="xmltag.org" >Ispire Technology Inc.</span></b></a> ("Ispire" or the "Company") (<a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4685825-1&amp;h=3905662850&amp;u=https%3A%2F%2Fwww.nasdaq.com%2Fmarket-activity%2Fstocks%2Fispr&amp;a=NASDAQ%3A+ISPR" target="_blank" rel="nofollow">NASDAQ: ISPR</a>), a trailblazer in vaping technology and precision dosing, announced that it has entered into a joint venture with <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4685825-1&amp;h=3130007742&amp;u=http%3A%2F%2Fwww.jinchengpharm.com%2Fwap_index_en.html&amp;a=Shandong+Jincheng+Pharmaceutical+Group+Co.%2C+Ltd." target="_blank" rel="nofollow"><span value="Shenzhen:300233" idsrc="xmltag.org" >Shandong Jincheng Pharmaceutical Group Co., Ltd.</span></a> (SZSE: 300233) ("Jincheng Pharma"), a global pharmaceutical company, to manufacture and commercialize nicotine pouch products.</p><div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder5003"><p><a target="_blank" href="https://mma.prnewswire.com/media/2771569/Ispire_Technology_Logo.html" http://www.streetinsider.com/Press+Releases/Ispire+Technology+Expands+Into+High-Growth+Nicotine+Pouch+Market+Through+Strategic+Joint+Venture+with+Jincheng+Pharma/26473674.html Tue, 12 May 2026 08:30:00 -0400 300233 ISPR O.07642199 O.57534732 http://www.streetinsider.com/PRNewswire/Ispire+Technology+Expands+Into+High-Growth+Nicotine+Pouch+Market+Through+Strategic+Joint+Venture+with+Jincheng+Pharma/26473674.html <div class="xn-content"> <p class="prntac"><i>Partnership combines pharmaceutical-grade manufacturing with Ispire's global platform to accelerate entry into one of the fastest-growing nicotine segments </i></p><p><span class="legendSpanClass"><location value="LU/us.ca.losang" idsrc="xmltag.org" >LOS ANGELES</location></span>, <span class="legendSpanClass"><chron>May 12, 2026</chron></span> /PRNewswire/ <b>-- </b><a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4685825-1&amp;h=609010424&amp;u=https%3A%2F%2Fispiretechnology.com%2F&amp;a=Ispire+Technology+Inc." target="_blank" rel="nofollow"><b><span value="NASDAQ-NMS:ISPR" idsrc="xmltag.org" >Ispire Technology Inc.</span></b></a> ("Ispire" or the "Company") (<a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4685825-1&amp;h=3905662850&amp;u=https%3A%2F%2Fwww.nasdaq.com%2Fmarket-activity%2Fstocks%2Fispr&amp;a=NASDAQ%3A+ISPR" target="_blank" rel="nofollow">NASDAQ: ISPR</a>), a trailblazer in vaping technology and precision dosing, announced that it has entered into a joint venture with <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4685825-1&amp;h=3130007742&amp;u=http%3A%2F%2Fwww.jinchengpharm.com%2Fwap_index_en.html&amp;a=Shandong+Jincheng+Pharmaceutical+Group+Co.%2C+Ltd." target="_blank" rel="nofollow"><span value="Shenzhen:300233" idsrc="xmltag.org" >Shandong Jincheng Pharmaceutical Group Co., Ltd.</span></a> (SZSE: 300233) ("Jincheng Pharma"), a global pharmaceutical company, to manufacture and commercialize nicotine pouch products.</p><div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder5003"><p><a target="_blank" href="https://mma.prnewswire.com/media/2771569/Ispire_Technology_Logo.html" http://www.streetinsider.com/PRNewswire/Ispire+Technology+Expands+Into+High-Growth+Nicotine+Pouch+Market+Through+Strategic+Joint+Venture+with+Jincheng+Pharma/26473674.html Tue, 12 May 2026 08:30:00 -0400 300233 ISPR O.07642199 O.57534732 http://www.streetinsider.com/PRNewswire/Ispire+Technology+Expands+Into+High-Growth+Nicotine+Pouch+Market+Through+Strategic+Joint+Venture+with+Jincheng+Pharma/26473674.html <div class="xn-content"> <p class="prntac"><i>Partnership combines pharmaceutical-grade manufacturing with Ispire's global platform to accelerate entry into one of the fastest-growing nicotine segments </i></p><p><span class="legendSpanClass"><location value="LU/us.ca.losang" idsrc="xmltag.org" >LOS ANGELES</location></span>, <span class="legendSpanClass"><chron>May 12, 2026</chron></span> /PRNewswire/ <b>-- </b><a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4685825-1&amp;h=609010424&amp;u=https%3A%2F%2Fispiretechnology.com%2F&amp;a=Ispire+Technology+Inc." target="_blank" rel="nofollow"><b><span value="NASDAQ-NMS:ISPR" idsrc="xmltag.org" >Ispire Technology Inc.</span></b></a> ("Ispire" or the "Company") (<a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4685825-1&amp;h=3905662850&amp;u=https%3A%2F%2Fwww.nasdaq.com%2Fmarket-activity%2Fstocks%2Fispr&amp;a=NASDAQ%3A+ISPR" target="_blank" rel="nofollow">NASDAQ: ISPR</a>), a trailblazer in vaping technology and precision dosing, announced that it has entered into a joint venture with <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4685825-1&amp;h=3130007742&amp;u=http%3A%2F%2Fwww.jinchengpharm.com%2Fwap_index_en.html&amp;a=Shandong+Jincheng+Pharmaceutical+Group+Co.%2C+Ltd." target="_blank" rel="nofollow"><span value="Shenzhen:300233" idsrc="xmltag.org" >Shandong Jincheng Pharmaceutical Group Co., Ltd.</span></a> (SZSE: 300233) ("Jincheng Pharma"), a global pharmaceutical company, to manufacture and commercialize nicotine pouch products.</p><div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder5003"><p><a target="_blank" href="https://mma.prnewswire.com/media/2771569/Ispire_Technology_Logo.html" http://www.streetinsider.com/PRNewswire/Ispire+Technology+Expands+Into+High-Growth+Nicotine+Pouch+Market+Through+Strategic+Joint+Venture+with+Jincheng+Pharma/26473674.html Tue, 12 May 2026 08:30:00 -0400 300233 ISPR O.07642199 O.57534732 http://www.streetinsider.com/PRNewswire/Ispire+Technology+Expands+Into+High-Growth+Nicotine+Pouch+Market+Through+Strategic+Joint+Venture+with+Jincheng+Pharma/26473674.html <div class="xn-content"> <p class="prntac"><i>Partnership combines pharmaceutical-grade manufacturing with Ispire's global platform to accelerate entry into one of the fastest-growing nicotine segments </i></p><p><span class="legendSpanClass"><location value="LU/us.ca.losang" idsrc="xmltag.org" >LOS ANGELES</location></span>, <span class="legendSpanClass"><chron>May 12, 2026</chron></span> /PRNewswire/ <b>-- </b><a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4685825-1&amp;h=609010424&amp;u=https%3A%2F%2Fispiretechnology.com%2F&amp;a=Ispire+Technology+Inc." target="_blank" rel="nofollow"><b><span value="NASDAQ-NMS:ISPR" idsrc="xmltag.org" >Ispire Technology Inc.</span></b></a> ("Ispire" or the "Company") (<a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4685825-1&amp;h=3905662850&amp;u=https%3A%2F%2Fwww.nasdaq.com%2Fmarket-activity%2Fstocks%2Fispr&amp;a=NASDAQ%3A+ISPR" target="_blank" rel="nofollow">NASDAQ: ISPR</a>), a trailblazer in vaping technology and precision dosing, announced that it has entered into a joint venture with <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4685825-1&amp;h=3130007742&amp;u=http%3A%2F%2Fwww.jinchengpharm.com%2Fwap_index_en.html&amp;a=Shandong+Jincheng+Pharmaceutical+Group+Co.%2C+Ltd." target="_blank" rel="nofollow"><span value="Shenzhen:300233" idsrc="xmltag.org" >Shandong Jincheng Pharmaceutical Group Co., Ltd.</span></a> (SZSE: 300233) ("Jincheng Pharma"), a global pharmaceutical company, to manufacture and commercialize nicotine pouch products.</p><div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder5003"><p><a target="_blank" href="https://mma.prnewswire.com/media/2771569/Ispire_Technology_Logo.html" http://www.streetinsider.com/PRNewswire/Ispire+Technology+Expands+Into+High-Growth+Nicotine+Pouch+Market+Through+Strategic+Joint+Venture+with+Jincheng+Pharma/26473674.html Tue, 12 May 2026 08:30:00 -0400 300233 ISPR O.07642199 O.57534732 http://www.streetinsider.com/PRNewswire/Ispire+Technology+Expands+Into+High-Growth+Nicotine+Pouch+Market+Through+Strategic+Joint+Venture+with+Jincheng+Pharma/26473674.html <div class="xn-content"> <p class="prntac"><i>Partnership combines pharmaceutical-grade manufacturing with Ispire's global platform to accelerate entry into one of the fastest-growing nicotine segments </i></p><p><span class="legendSpanClass"><location value="LU/us.ca.losang" idsrc="xmltag.org" >LOS ANGELES</location></span>, <span class="legendSpanClass"><chron>May 12, 2026</chron></span> /PRNewswire/ <b>-- </b><a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4685825-1&amp;h=609010424&amp;u=https%3A%2F%2Fispiretechnology.com%2F&amp;a=Ispire+Technology+Inc." target="_blank" rel="nofollow"><b><span value="NASDAQ-NMS:ISPR" idsrc="xmltag.org" >Ispire Technology Inc.</span></b></a> ("Ispire" or the "Company") (<a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4685825-1&amp;h=3905662850&amp;u=https%3A%2F%2Fwww.nasdaq.com%2Fmarket-activity%2Fstocks%2Fispr&amp;a=NASDAQ%3A+ISPR" target="_blank" rel="nofollow">NASDAQ: ISPR</a>), a trailblazer in vaping technology and precision dosing, announced that it has entered into a joint venture with <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4685825-1&amp;h=3130007742&amp;u=http%3A%2F%2Fwww.jinchengpharm.com%2Fwap_index_en.html&amp;a=Shandong+Jincheng+Pharmaceutical+Group+Co.%2C+Ltd." target="_blank" rel="nofollow"><span value="Shenzhen:300233" idsrc="xmltag.org" >Shandong Jincheng Pharmaceutical Group Co., Ltd.</span></a> (SZSE: 300233) ("Jincheng Pharma"), a global pharmaceutical company, to manufacture and commercialize nicotine pouch products.</p><div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder5003"><p><a target="_blank" href="https://mma.prnewswire.com/media/2771569/Ispire_Technology_Logo.html" http://www.streetinsider.com/PRNewswire/Ispire+Technology+Expands+Into+High-Growth+Nicotine+Pouch+Market+Through+Strategic+Joint+Venture+with+Jincheng+Pharma/26473674.html Tue, 12 May 2026 08:30:00 -0400 300233 ISPR O.07642199 O.57534732 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Ispire+Technology+Inc.++++For%3A+Mar+31/26454304.html si-local-file:///var/storage/secattach/20260507/26454304.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Ispire+Technology+Inc.++++For%3A+Mar+31/26454304.html Thu, 07 May 2026 16:32:00 -0400 ISPR O.57534732 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Ispire+Technology+Inc.++++For%3A+Mar+31/26454304.html si-local-file:///var/storage/secattach/20260507/26454304.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Ispire+Technology+Inc.++++For%3A+Mar+31/26454304.html Thu, 07 May 2026 16:32:00 -0400 ISPR O.57534732 http://www.streetinsider.com/Earnings/Ispire+Technology+Inc.+%28ISPR%29+Misses+Q3+EPS+by+13c/26448173.html <p>Ispire Technology Inc. (NASDAQ: ISPR) reported Q3 EPS of ($0.17), $0.13 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $18.4 million.</p><p>For earnings history and earnings-related data on Ispire Technology Inc. (ISPR) <a href="http://www.streetinsider.com/ec_earnings.php?q=ISPR">click here</a>.</p> http://www.streetinsider.com/Earnings/Ispire+Technology+Inc.+%28ISPR%29+Misses+Q3+EPS+by+13c/26448173.html Thu, 07 May 2026 07:19:33 -0400 ISPR http://www.streetinsider.com/Press+Releases/Ispire+Technology+Inc.+Reports+Financial+Results+for+Fiscal+Third+Quarter+2026/26447763.html <div class="xn-content"> <p class="prntac"><i>Cash Increased Sequentially by <money>$468,000</money> to <money>$18 Million</money></i></p><p class="prntac"><i>Plans to Achieve Cash Flow Positive in Second Half of Calendar Year 2026 </i></p><p class="prntac"><i>Business Stabilized Following Strategic Repositioning</i></p><p class="prntac"><i>Phased Roadmap Targets Billions in Addressable Market, Including <money>~$73B</money> Global Vape, ~$50–70B <location value="LC/us" idsrc="xmltag.org" >U.S.</location> Flavored Vape, and $24B+ Global G-Mesh Glass Technology</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.losang" idsrc="xmltag.org" >LOS ANGELES</location></span>, <span class="legendSpanClass"><chron>May 7, 2026</chron></span> /PRNewswire/ -- <u style="font-weight: bold;">Ispire</u><u style="font-weight: bold;"> <span>Technology Inc.</span></u> (Nasdaq: ISPR) ("Ispire," the "Company," "we," "us," or "our"), an innovator in vaping technology and precision dosing, today reported financial results for the third quarter of fiscal 2026, for the three http://www.streetinsider.com/Press+Releases/Ispire+Technology+Inc.+Reports+Financial+Results+for+Fiscal+Third+Quarter+2026/26447763.html Thu, 07 May 2026 07:00:00 -0400 ISPR O.57534732 http://www.streetinsider.com/Press+Releases/Ispire+Technology+Inc.+Reports+Financial+Results+for+Fiscal+Third+Quarter+2026/26447763.html <div class="xn-content"> <p class="prntac"><i>Cash Increased Sequentially by <money>$468,000</money> to <money>$18 Million</money></i></p><p class="prntac"><i>Plans to Achieve Cash Flow Positive in Second Half of Calendar Year 2026 </i></p><p class="prntac"><i>Business Stabilized Following Strategic Repositioning</i></p><p class="prntac"><i>Phased Roadmap Targets Billions in Addressable Market, Including <money>~$73B</money> Global Vape, ~$50–70B <location value="LC/us" idsrc="xmltag.org" >U.S.</location> Flavored Vape, and $24B+ Global G-Mesh Glass Technology</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.losang" idsrc="xmltag.org" >LOS ANGELES</location></span>, <span class="legendSpanClass"><chron>May 7, 2026</chron></span> /PRNewswire/ -- <u style="font-weight: bold;">Ispire</u><u style="font-weight: bold;"> <span>Technology Inc.</span></u> (Nasdaq: ISPR) ("Ispire," the "Company," "we," "us," or "our"), an innovator in vaping technology and precision dosing, today reported financial results for the third quarter of fiscal 2026, for the three http://www.streetinsider.com/Press+Releases/Ispire+Technology+Inc.+Reports+Financial+Results+for+Fiscal+Third+Quarter+2026/26447763.html Thu, 07 May 2026 07:00:00 -0400 ISPR O.57534732 http://www.streetinsider.com/PRNewswire/Ispire+Technology+Inc.+Reports+Financial+Results+for+Fiscal+Third+Quarter+2026/26447763.html <div class="xn-content"> <p class="prntac"><i>Cash Increased Sequentially by <money>$468,000</money> to <money>$18 Million</money></i></p><p class="prntac"><i>Plans to Achieve Cash Flow Positive in Second Half of Calendar Year 2026 </i></p><p class="prntac"><i>Business Stabilized Following Strategic Repositioning</i></p><p class="prntac"><i>Phased Roadmap Targets Billions in Addressable Market, Including <money>~$73B</money> Global Vape, ~$50–70B <location value="LC/us" idsrc="xmltag.org" >U.S.</location> Flavored Vape, and $24B+ Global G-Mesh Glass Technology</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.losang" idsrc="xmltag.org" >LOS ANGELES</location></span>, <span class="legendSpanClass"><chron>May 7, 2026</chron></span> /PRNewswire/ -- <u style="font-weight: bold;">Ispire</u><u style="font-weight: bold;"> <span>Technology Inc.</span></u> (Nasdaq: ISPR) ("Ispire," the "Company," "we," "us," or "our"), an innovator in vaping technology and precision dosing, today reported financial results for the third quarter of fiscal 2026, for the three http://www.streetinsider.com/PRNewswire/Ispire+Technology+Inc.+Reports+Financial+Results+for+Fiscal+Third+Quarter+2026/26447763.html Thu, 07 May 2026 07:00:00 -0400 ISPR O.57534732 http://www.streetinsider.com/PRNewswire/Ispire+Technology+Inc.+Reports+Financial+Results+for+Fiscal+Third+Quarter+2026/26447763.html <div class="xn-content"> <p class="prntac"><i>Cash Increased Sequentially by <money>$468,000</money> to <money>$18 Million</money></i></p><p class="prntac"><i>Plans to Achieve Cash Flow Positive in Second Half of Calendar Year 2026 </i></p><p class="prntac"><i>Business Stabilized Following Strategic Repositioning</i></p><p class="prntac"><i>Phased Roadmap Targets Billions in Addressable Market, Including <money>~$73B</money> Global Vape, ~$50–70B <location value="LC/us" idsrc="xmltag.org" >U.S.</location> Flavored Vape, and $24B+ Global G-Mesh Glass Technology</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.losang" idsrc="xmltag.org" >LOS ANGELES</location></span>, <span class="legendSpanClass"><chron>May 7, 2026</chron></span> /PRNewswire/ -- <u style="font-weight: bold;">Ispire</u><u style="font-weight: bold;"> <span>Technology Inc.</span></u> (Nasdaq: ISPR) ("Ispire," the "Company," "we," "us," or "our"), an innovator in vaping technology and precision dosing, today reported financial results for the third quarter of fiscal 2026, for the three http://www.streetinsider.com/PRNewswire/Ispire+Technology+Inc.+Reports+Financial+Results+for+Fiscal+Third+Quarter+2026/26447763.html Thu, 07 May 2026 07:00:00 -0400 ISPR O.57534732 http://www.streetinsider.com/Press+Releases/Ispire+Technology+Inc.+Schedules+Fiscal+Third+Quarter+2026+Earnings+Conference+Call/26411801.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.losang" idsrc="xmltag.org" >LOS ANGELES</location></span>, <span class="legendSpanClass"><chron>May 1, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:ISPR" idsrc="xmltag.org" >Ispire Technology Inc.</span> ("Ispire" or the "Company") (NASDAQ: ISPR), a trailblazer in vaping technology and precision dosing, announced today that it will host its earnings conference call at <chron>8:00 am ET</chron> on <chron>Thursday, May 7, 2026</chron>, to discuss the Company's financial results for its fiscal third quarter ended <chron>March 31, 2026</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Ispire+Technology+Inc.+Schedules+Fiscal+Third+Quarter+2026+Earnings+Conference+Call/26411801.html Fri, 01 May 2026 07:00:00 -0400 ISPR O.57534732 http://www.streetinsider.com/Press+Releases/Ispire+Technology+Inc.+Schedules+Fiscal+Third+Quarter+2026+Earnings+Conference+Call/26411801.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.losang" idsrc="xmltag.org" >LOS ANGELES</location></span>, <span class="legendSpanClass"><chron>May 1, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:ISPR" idsrc="xmltag.org" >Ispire Technology Inc.</span> ("Ispire" or the "Company") (NASDAQ: ISPR), a trailblazer in vaping technology and precision dosing, announced today that it will host its earnings conference call at <chron>8:00 am ET</chron> on <chron>Thursday, May 7, 2026</chron>, to discuss the Company's financial results for its fiscal third quarter ended <chron>March 31, 2026</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Ispire+Technology+Inc.+Schedules+Fiscal+Third+Quarter+2026+Earnings+Conference+Call/26411801.html Fri, 01 May 2026 07:00:00 -0400 ISPR O.57534732